Jeremy Ramdial

1.5k total citations
62 papers, 310 citations indexed

About

Jeremy Ramdial is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Jeremy Ramdial has authored 62 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 28 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Jeremy Ramdial's work include Hematopoietic Stem Cell Transplantation (15 papers), Acute Myeloid Leukemia Research (15 papers) and CAR-T cell therapy research (14 papers). Jeremy Ramdial is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Acute Myeloid Leukemia Research (15 papers) and CAR-T cell therapy research (14 papers). Jeremy Ramdial collaborates with scholars based in United States, Israel and Canada. Jeremy Ramdial's co-authors include Richard E. Champlin, Elizabeth J. Shpall, Partow Kebriaei, Juan Pablo Alderuccio, Isildinha M. Reis, Nicolas Gallastegui, Jennifer R. Chapman, Amrita Desai, Wei Zhao and Joseph D. Rosenblatt and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jeremy Ramdial

53 papers receiving 306 citations

Peers

Countries citing papers authored by Jeremy Ramdial

Since Specialization

Citations

This map shows the geographic impact of Jeremy Ramdial's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy Ramdial with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy Ramdial more than expected).

Fields of papers citing papers by Jeremy Ramdial

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy Ramdial. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy Ramdial. The network helps show where Jeremy Ramdial may publish in the future.

Co-authorship network of co-authors of Jeremy Ramdial

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy Ramdial. A scholar is included among the top collaborators of Jeremy Ramdial based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy Ramdial. Jeremy Ramdial is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxis 2025 ·Blood Advances ·Yosra Aljawai, Jeremy Ramdial, Gabriela Rondón, (unknown), Partow Kebriaei, Uday Popat, Betül Oran, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Rohtesh S. Mehta	2
2	TP53-mutant variant allele frequency and cytogenetics determine prognostic groups in MDS/AML for transplantation 2025 ·Blood Advances ·Konstantinos Lontos, Rima M. Saliba, Rashmi Kanagal‐Shamanna, (unknown), Jeremy Ramdial, George L. Chen, Tapan M. Kadia, Nicholas J. Short, Naval Daver, Hagop M. Kantarjian, (unknown), Partow Kebriaei, Uday Popat, Richard E. Champlin, Elizabeth J. Shpall, Betül Oran	4
3	P-1013. Incidence and Risk Factors for Fungal Infection after CD19-targeted Chimeric Antigen Receptor T cell Therapy for Non-Hodgkin Lymphoma 2025 ·Open Forum Infectious Diseases ·(unknown), Roy F. Chemaly, Ying Jiang, Jeremy Ramdial, Sairah Ahmed, (unknown), Ella Ariza‐Heredia, Amy Spallone, Swaminathan P. Iyer, (unknown), (unknown), (unknown), Loretta J. Nastoupil, Fareed Khawaja	1
4	Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma 2025 ·Clinical Cancer Research ·Yago Nieto, Jeremy Ramdial, Benigno C. Valdez, Peter F. Thall, Roland L. Bassett, M. J. Barnett, Samer A. Srour, Chitra Hosing, Amin M. Alousi, Muzaffar H. Qazilbash, Uday Popat, Alison Gulbis, Terri Lynn Shigle, Sairah Ahmed, (unknown), Richard E. Champlin, Elizabeth J. Shpall, Börje S. Andersson	1
5	Phase II Clinical Trial of “Off-the-Shelf” NK Cells with Allogeneic Stem Cell Transplantation in Patients with High-Risk Myeloid Malignancies 2024 ·Blood ·Jeremy Ramdial, Laura Di Clemente, Pinaki P. Banerjee, Bouthaina S. Dabaja, Gheath Alatrash, Amin M. Alousi, Betül Oran, (unknown), Jin S. Im, Samer A. Srour, George Chen, Partow Kebriaei, Chitra Hosing, (unknown), Katayoun Rezvani, Elizabeth J. Shpall, Richard Champlin	0
6	Factors associated with manufacturing failure of commercial CD19 CAR-T cell products for large b cell lymphoma (LBCL). 2024 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), Jason R. Westin, Loretta J. Nastoupil, Ranjit Nair, Swaminathan P. Iyer, (unknown), Yago Nieto, Partow Kebriaei, Misha Hawkins, Dai Chihara, Luis Malpica, Sherry Adkins, Elizabeth J. Shpall, Jeremy Ramdial, Paolo Strati, Chitra Hosing, Sattva S. Neelapu, Sairah Ahmed	4
7	Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies 2024 ·Blood Advances ·(unknown), Stefan O. Ciurea, Uday Popat, Jeremy Ramdial, Qaiser Bashir, Amin M. Alousi, Julianne Chen, Gabriela Rondón, Amanda Olson, Jin S. Im, Chitra Hosing, Elizabeth J. Shpall, Richard E. Champlin, Samer A. Srour	2
8	Cytomegaloviral Infections in Recipients of Chimeric Antigen Receptor T-Cell Therapy: An Observational Study With Focus on Oncologic Outcomes 2024 ·Open Forum Infectious Diseases ·Fareed Khawaja, Sairah Ahmed, Swaminathan P. Iyer, Joseph Sassine, (unknown), (unknown), (unknown), Jennifer Jackson, (unknown), Jeremy Ramdial, Gabriela Rondón, Krina K. Patel, Amy Spallone, Ella Ariza‐Heredia, Victor E. Mulanovich, (unknown), Ying Jiang, Roy F. Chemaly	11
9	Haploidentical vs HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerations 2024 ·Blood Advances ·Rohtesh S. Mehta, Jeremy Ramdial, Partow Kebriaei, Richard E. Champlin, Uday Popat, (unknown), Elizabeth J. Shpall	2
10	HLA-DPB1 Mismatches and the Impact on Unrelated Donor Transplant Outcomes with the Use of Post-Transplant Cyclophosphamide 2024 ·Blood ·(unknown), (unknown), Rima M. Saliba, (unknown), Warren Fingrut, Yosra Aljawai, Amanda Olson, Amin M. Alousi, George L. Chen, Jeremy Ramdial, Richard E. Champlin, Elizabeth J. Shpall, Betül Oran	0
11	Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative Conditioning 2023 ·Transplantation and Cellular Therapy ·Jacinth Joseph, Samer A. Srour, Denái R. Milton, Jeremy Ramdial, Neeraj Saini, Amanda Olson, Qaiser Bashir, Betül Oran, Amin M. Alousi, Chitra Hosing, Muzaffar H. Qazilbash, Partow Kebriaei, Elizabeth J. Shpall, Richard E. Champlin, Uday Popat	3
12	Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation 2023 ·Cancer ·Oren Pasvolsky, (unknown), Roland L. Bassett, Hina Khan, Mark R. Tanner, Qaiser Bashir, Samer A. Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Hans C. Lee, Krina K. Patel, Partow Kebriaei, Sheeba K. Thomas, Donna M. Weber, Robert Z. Orlowski, Elizabeth J. Shpall, Richard E. Champlin, Muzaffar H. Qazilbash	1
13	Outcomes of Autologous Stem Cell Transplantation in Patients with Ultra-High-Risk Multiple Myeloma 2023 ·Transplantation and Cellular Therapy ·Oren Pasvolsky, (unknown), Denái R. Milton, (unknown), Mark R. Tanner, Qaiser Bashir, Samer A. Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Hans C. Lee, Krina K. Patel, Partow Kebriaei, Sheeba K. Thomas, Donna M. Weber, Robert Z. Orlowski, Elizabeth J. Shpall, Richard E. Champlin, Muzaffar H. Qazilbash	8
14	Impact of Donor Age in Haploidentical-Post-Transplantation Cyclophosphamide versus Matched Unrelated Donor Post-Transplantation Cyclophosphamide Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia 2023 ·Transplantation and Cellular Therapy ·Rohtesh S. Mehta, Jeremy Ramdial, David Marín, Amin M. Alousi, Christopher G. Kanakry, Richard E. Champlin, Katayoun Rezvani, Elizabeth J. Shpall, Kristin Page, Shahinaz M. Gadalla, Partow Kebriaei, Daniel J. Weisdorf	14
15	Herpesviruses Infections in CAR T Cell Recipients 2022 ·Transplantation and Cellular Therapy ·Fareed Khawaja, Joseph Sassine, (unknown), Swaminathan P. Iyer, Jeremy Ramdial, Sairah Ahmed, Yago Nieto, Amy Spallone, Ella Ariza‐Heredia, Roy F. Chemaly	3
16	Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple Myeloma 2022 ·Transplantation and Cellular Therapy ·Oren Pasvolsky, Denái R. Milton, (unknown), Mark R. Tanner, Qaiser Bashir, Samer A. Srour, Guilin Tang, Neeraj Saini, Jeremy Ramdial, (unknown), Yago Nieto, Hans C. Lee, Krina K. Patel, Partow Kebriaei, Sheeba K. Thomas, Donna M. Weber, Robert Z. Orlowski, Elizabeth J. Shpall, Richard E. Champlin, Muzaffar H. Qazilbash	4
17	Post-Transplantation Cyclophosphamide Versus Tacrolimus and Methotrexate Graft-Versus-Host Disease Prophylaxis for HLA-Matched Donor Transplantation 2022 ·Transplantation and Cellular Therapy ·Rohtesh S. Mehta, Rima M. Saliba, Gabriela Rondón, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Partow Kebriaei, Issa F. Khouri, Yago Nieto, Betül Oran, Uday Popat, Muzaffar H. Qazilbash, Jeremy Ramdial, Samer A. Srour, Richard E. Champlin, Katayoun Rezvani, Elizabeth J. Shpall, Amin M. Alousi	23
18	The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways 2021 ·Cancer Research Communications ·Marco Magistri, Lanie E. Happ, Jeremy Ramdial, Xiaoqing Lu, Vasileios Stathias, Kranthi Kunkalla, Nitin Agarwal, Xiaoyu Jiang, Stephan C. Schürer, Sander R. Dubovy, Jennifer R. Chapman, Francisco Vega, Sandeep S. Davé, Izidore S. Lossos	8
19	Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation 2019 ·American Journal of Hematology ·Juan Pablo Alderuccio, Wei Zhao, Amrita Desai, Jeremy Ramdial, Nicolas Gallastegui, Erik L. Kimble, Macarena I. de la Fuente, Muhammad Husnain, Joseph D. Rosenblatt, Alvaro J. Alencar, Jonathan H. Schatz, Craig H. Moskowitz, Jennifer R. Chapman, Francisco Vega, Isildinha M. Reis, Izidore S. Lossos	26
20	Vinorelbine plus Capecitabine (Vinocap): a retrospective analysis in heavily pretreated HER2 negative metastatic breast cancer patients 2019 ·Breast Cancer Research and Treatment ·(unknown), Jeremy Ramdial, Luis E. Aguirre, Reshma Mahtani, Charles L. Vogel	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact